Novel oligonucleotide-based sorbent for the selective extraction of cadmium from serum samples.

Aptamers Cadmium ICP-MS Oligoextraction Solid-phase extraction

Journal

Journal of pharmaceutical and biomedical analysis
ISSN: 1873-264X
Titre abrégé: J Pharm Biomed Anal
Pays: England
ID NLM: 8309336

Informations de publication

Date de publication:
05 Jan 2024
Historique:
received: 22 08 2023
revised: 03 10 2023
accepted: 04 10 2023
medline: 3 11 2023
pubmed: 14 10 2023
entrez: 13 10 2023
Statut: ppublish

Résumé

The objective was to develop a sorbent functionalized with aptamers for the selective extraction of cadmium from biological samples. Two oligonucleotide sequences reported in literature as specific to cadmium were covalently grafted on activated Sepharose, with grafting yields of 45%. Once the supports packed in cartridges, a thorough study of the percolation conditions favoring Cd(II) retention was performed, demonstrating the importance of the nature of this medium. A high selectivity was reached when applying the optimal conditions as a recovery of 85% was obtained using the sorbent functionalized with one of the specific aptamers and only 1% on the control sorbent grafted with a scramble sequence. A high specificity was also obtained as recoveries for most of other ions were lower than 15%. The capacity of this oligosorbent estimated to 180 ng of Cd(II) for 30 mg of support was perfectly adapted to the trace analysis of Cd(II). The extraction procedure was then applied to a serum sample which was first subjected to acid precipitation. The initial concentration of cadmium in the serum was estimated to 1.83 µg/L using standard addition method and an extraction yield of 75 ± 1.6% was measured. Comparison of these results with those obtained without oligoextraction (recovery of 57%) showed a significant reduction of matrix effects in ICP-MS thanks to the use of the oligosorbent, underlining its interest for a more reliable quantification of Cd(II). This result was confirmed by performing the oligoextraction protocol on a certified serum.

Identifiants

pubmed: 37832475
pii: S0731-7085(23)00540-X
doi: 10.1016/j.jpba.2023.115771
pii:
doi:

Substances chimiques

Cadmium 00BH33GNGH
Aptamers, Nucleotide 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

115771

Informations de copyright

Copyright © 2023 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Fanny Gignac (F)

Department of Analytical, Bioanalytical Sciences, and Miniaturization (LSABM), UMR 8231 Chemistry, Biology and Innovation (CBI), ESPCI Paris, PSL University, CNRS, 10 rue Vauquelin, Paris 75005, France; Sorbonne Université, 4 place jussieu, Paris 75005, France.

Nathalie Delaunay (N)

Department of Analytical, Bioanalytical Sciences, and Miniaturization (LSABM), UMR 8231 Chemistry, Biology and Innovation (CBI), ESPCI Paris, PSL University, CNRS, 10 rue Vauquelin, Paris 75005, France.

Valérie Pichon (V)

Department of Analytical, Bioanalytical Sciences, and Miniaturization (LSABM), UMR 8231 Chemistry, Biology and Innovation (CBI), ESPCI Paris, PSL University, CNRS, 10 rue Vauquelin, Paris 75005, France; Sorbonne Université, 4 place jussieu, Paris 75005, France. Electronic address: valerie.pichon@espci.fr.

Articles similaires

Classifications MeSH